SynAir-Child
DeviceMonitor the indoor pollutants and their effect on children well being
NCT Number: NCT05105386
To quantify health effects of synergizing chemical and biological pollutants in a targeted population setting, i.e., school-aged children. Indoor air pollutants will be monitored within the classrooms with high end sensors. Exposure data from additional sources (outdoor, home, transports) will be obtained. Health outcomes will be assessed prospectively using validated medical procedures and real-time tracking with mobile health (mHealth) equipment and a gamified computer app.
Trial opening soon.
Get Notified8 year–9 year
All sexes
Observational
Communication with individual schools and families representing diverse cultural and socioeconomic backgrounds, will be conducted and formal participation consents obtained. The target population will include healthy children and be enriched for children with respiratory allergies and asthma. Provision of instructions, training for participation and baseline assessments of respiratory, immune, and mental health using questionnaires and relevant physiological measurements (e.g spirometry, FeNO), will be performed. Sensors will be positioned and cross-checked for functionality.Health data from the cohort will be monitored by a specifically designed gamified application, as well as by state-of-the-art wearable tracking technology. The app will capture input from the participants at large, while the trackers will accurately, continuously, and remotely, identify personalized patterns of all day activity status, heart rate, oxygen saturation, temperature, blood pressure, sleep, respiratory rate, and mechano-acoustic breathing sounds signatures. Sentinel data will be processed in Work Package 6 and integrated in the SynAir-G autonomous sensing platform.
Children will be prospectively followed-up for a school year. Investigators will regularly visit schools to keep sensors running and collect materials. Real-time tracking will be coupled with regular communication and face-to-face visits for health outcome assessments. Devices will be positioned in selected locations. The cohort will also provide the setting for establishing indoor and outdoor interactions, dose-responses in real life, and health outcome data for integration and synergy analyses.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Unwilling to use the application and follow the procedures of the protocol
Monitor the indoor pollutants and their effect on children well being
Time frame: One year
Questionnaires
Time frame: One year
RNA Sequency/CRP
Time frame: One year
DNA damage levels in blood cells
Time frame: One year
Spirometry
Time frame: One year
Exhaled nitric oxide
Time frame: One year
Breath biopsy
Time frame: One year
Wearables
Time frame: One year
Height in cm and weight in kg will be combined to report BMI (kg/m^2)
Contact information is provided by the study sponsor or research team.
NIKOLAOS G PAPADOPOULOS, Professor
CONTACT
PARASKEVI XEPAPADAKI, Assoc. Prof.
CONTACT
National and Kapodistrian University of Athens
Other
Acronym: SynAir-Child
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06529913
Allergic Contact Dermatitis, Aluminum Allergy
Bologna, Italy
View Trial DetailsNCT06588530
Actinomycetales Infections, Adult
Paulsboro, New Jersey, United States
View Trial DetailsNCT04068389
Female Urogenital Diseases and Pregnancy Complications, Lung; Premature
View Trial DetailsNCT07641413
Cardiopulmonary, Dyspnea
San Francisco, California, United States
View Trial Details